ALMEBEX Trademark

Trademark Overview


On Tuesday, March 26, 2013, a trademark application was filed for ALMEBEX with the United States Patent and Trademark Office. The USPTO has given the ALMEBEX trademark a serial number of 85886460. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, July 17, 2024. This trademark is owned by New Pharma, Inc.. The ALMEBEX trademark is filed in the Pharmaceutical Products category with the following description:

dietary supplements, namely, over the counter multivitamins
almebex

General Information


Serial Number85886460
Word MarkALMEBEX
Filing DateTuesday, March 26, 2013
Status800 - REGISTERED AND RENEWED
Status DateWednesday, July 17, 2024
Registration Number4532047
Registration DateTuesday, May 20, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 4, 2014

Trademark Statements


Goods and Servicesdietary supplements, namely, over the counter multivitamins

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 29, 2013
Primary Code005
First Use Anywhere DateWednesday, November 30, 1983
First Use In Commerce DateWednesday, November 30, 1983

Trademark Owner History


Party NameALDAMA PHARMACEUTICALS, INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressMIAMI, FL 33122

Party NameNEWPHARMA INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressMIAMI, FL 33122

Party NameNew Pharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMiami, FL 33122

Party NameNew Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMiami, FL 33122

Party NameNew Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiami, FL 33122

Trademark Events


Event DateEvent Description
Monday, July 8, 2013ASSIGNED TO EXAMINER
Tuesday, July 9, 2013NON-FINAL ACTION WRITTEN
Tuesday, July 9, 2013NON-FINAL ACTION E-MAILED
Tuesday, July 9, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 7, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 7, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 7, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 30, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 4, 2014PUBLISHED FOR OPPOSITION
Tuesday, May 20, 2014REGISTERED-PRINCIPAL REGISTER
Monday, May 20, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, March 29, 2013NEW APPLICATION ENTERED
Friday, March 29, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 8, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 30, 2014ASSIGNED TO LIE
Wednesday, February 12, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 4, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 4, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, May 20, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, March 31, 2020TEAS SECTION 8 & 15 RECEIVED
Wednesday, May 27, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, May 28, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, May 28, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, April 23, 2024TEAS SECTION 8 & 9 RECEIVED
Wednesday, July 17, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, July 17, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, July 17, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, September 24, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, July 17, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED